About the Authors

Thomas Lind

thomas.lind@medsci.uu.se

Affiliation Uppsala University Hospital, Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala, Sweden

Ann-Marie Gustafson

Affiliations Uppsala University Hospital, Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala, Sweden, Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden

Gabriela Calounova

Affiliation Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden

Lijuan Hu

Affiliation Uppsala University Hospital, Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala, Sweden

Annica Rasmusson

Affiliation Uppsala University Hospital, Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala, Sweden

Kenneth B. Jonsson

Affiliation Uppsala University Hospital, Department of Surgical Sciences, Uppsala, Sweden

Sara Wernersson

Affiliation Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry, Uppsala, Sweden

Magnus Åbrink

Affiliation Swedish University of Agricultural Sciences, Department of Biomedical Science and Veterinary Public Health, Uppsala, Sweden

Göran Andersson

Affiliation Karolinska Institute, Division of Pathology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden

Sune Larsson

Affiliation Uppsala University Hospital, Department of Surgical Sciences, Uppsala, Sweden

Håkan Melhus

Affiliation Uppsala University Hospital, Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala, Sweden

Gunnar Pejler

Affiliations Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden, Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry, Uppsala, Sweden

Competing Interests

No competing interest exist. The funding from Uppsala Bio-X does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: TL GP HM. Formal analysis: TL. Funding acquisition: TL GP. Investigation: TL AMG GC LH KBJ SW MÅ GA SL AR. Methodology: TL GP. Resources: GP SL. Visualization: TL. Writing – original draft: TL GP. Writing – review & editing: TL KBJ SW MÅ GA SL HM GP AR.